The incidence and cost of cardiac surgery adverse events in Australian (Victorian) hospitals 2003-2004

Johnathon P Ehsani, Stephen J. Duckett, Terri Jackson

Research output: Contribution to journalArticle

Abstract

The aim of this study was to estimate the incidence of adverse events in acute surgical admissions for cardiac disease in admitted episodes in the year 2003-2004 and to estimate the cost of these complications to the Victorian health system. Cardiac surgery adverse events are among the most frequent and significant contributors to the morbidity, mortality and cost associated with hospitalisation. Patient-level costing data set for major Victorian public hospitals in 2003-2004 was analysed for adverse events using C-prefixed markers, denoting complications that arose during the course of hospital treatment for cardiac surgery diagnosis related groups (DRGs). The cost of adverse events was estimated by linear regression modelling, adjusted for age and co-morbidity. A total of 16,766 multi-day cardiac disease cases were identified, of whom 6,181 (36.85%) had at least one adverse event. Patients with adverse events stayed approximately 7 days longer and had four times the case fatality rate than those without. After adjustment for age and co-morbidity, the presence of an adverse event adds AUS$5,751. The sum of the total cost of adverse events for each DRG was AUS$42.855 million, representing 21.6% of total expenditure on cardiac surgery and adding 27.5% in broad terms to the cardiac surgery budget.

Original languageEnglish (US)
Pages (from-to)339-346
Number of pages8
JournalEuropean Journal of Health Economics
Volume8
Issue number4
DOIs
StatePublished - Dec 2007
Externally publishedYes

Fingerprint

Thoracic Surgery
Costs and Cost Analysis
Diagnosis-Related Groups
Incidence
Morbidity
Heart Diseases
Mortality
Public Hospitals
Budgets
Health Expenditures
Linear Models
Hospitalization
Adverse events
Costs
Cardiac surgery
Health
Therapeutics

Keywords

  • Adverse events
  • Costs
  • Health economics
  • Patient safety

ASJC Scopus subject areas

  • Economics, Econometrics and Finance (miscellaneous)
  • Health Policy

Cite this

The incidence and cost of cardiac surgery adverse events in Australian (Victorian) hospitals 2003-2004. / Ehsani, Johnathon P; Duckett, Stephen J.; Jackson, Terri.

In: European Journal of Health Economics, Vol. 8, No. 4, 12.2007, p. 339-346.

Research output: Contribution to journalArticle

@article{6d854d25faaa4c9abab8b821171f89f3,
title = "The incidence and cost of cardiac surgery adverse events in Australian (Victorian) hospitals 2003-2004",
abstract = "The aim of this study was to estimate the incidence of adverse events in acute surgical admissions for cardiac disease in admitted episodes in the year 2003-2004 and to estimate the cost of these complications to the Victorian health system. Cardiac surgery adverse events are among the most frequent and significant contributors to the morbidity, mortality and cost associated with hospitalisation. Patient-level costing data set for major Victorian public hospitals in 2003-2004 was analysed for adverse events using C-prefixed markers, denoting complications that arose during the course of hospital treatment for cardiac surgery diagnosis related groups (DRGs). The cost of adverse events was estimated by linear regression modelling, adjusted for age and co-morbidity. A total of 16,766 multi-day cardiac disease cases were identified, of whom 6,181 (36.85{\%}) had at least one adverse event. Patients with adverse events stayed approximately 7 days longer and had four times the case fatality rate than those without. After adjustment for age and co-morbidity, the presence of an adverse event adds AUS$5,751. The sum of the total cost of adverse events for each DRG was AUS$42.855 million, representing 21.6{\%} of total expenditure on cardiac surgery and adding 27.5{\%} in broad terms to the cardiac surgery budget.",
keywords = "Adverse events, Costs, Health economics, Patient safety",
author = "Ehsani, {Johnathon P} and Duckett, {Stephen J.} and Terri Jackson",
year = "2007",
month = "12",
doi = "10.1007/s10198-006-0036-z",
language = "English (US)",
volume = "8",
pages = "339--346",
journal = "European Journal of Health Economics",
issn = "1618-7598",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - The incidence and cost of cardiac surgery adverse events in Australian (Victorian) hospitals 2003-2004

AU - Ehsani, Johnathon P

AU - Duckett, Stephen J.

AU - Jackson, Terri

PY - 2007/12

Y1 - 2007/12

N2 - The aim of this study was to estimate the incidence of adverse events in acute surgical admissions for cardiac disease in admitted episodes in the year 2003-2004 and to estimate the cost of these complications to the Victorian health system. Cardiac surgery adverse events are among the most frequent and significant contributors to the morbidity, mortality and cost associated with hospitalisation. Patient-level costing data set for major Victorian public hospitals in 2003-2004 was analysed for adverse events using C-prefixed markers, denoting complications that arose during the course of hospital treatment for cardiac surgery diagnosis related groups (DRGs). The cost of adverse events was estimated by linear regression modelling, adjusted for age and co-morbidity. A total of 16,766 multi-day cardiac disease cases were identified, of whom 6,181 (36.85%) had at least one adverse event. Patients with adverse events stayed approximately 7 days longer and had four times the case fatality rate than those without. After adjustment for age and co-morbidity, the presence of an adverse event adds AUS$5,751. The sum of the total cost of adverse events for each DRG was AUS$42.855 million, representing 21.6% of total expenditure on cardiac surgery and adding 27.5% in broad terms to the cardiac surgery budget.

AB - The aim of this study was to estimate the incidence of adverse events in acute surgical admissions for cardiac disease in admitted episodes in the year 2003-2004 and to estimate the cost of these complications to the Victorian health system. Cardiac surgery adverse events are among the most frequent and significant contributors to the morbidity, mortality and cost associated with hospitalisation. Patient-level costing data set for major Victorian public hospitals in 2003-2004 was analysed for adverse events using C-prefixed markers, denoting complications that arose during the course of hospital treatment for cardiac surgery diagnosis related groups (DRGs). The cost of adverse events was estimated by linear regression modelling, adjusted for age and co-morbidity. A total of 16,766 multi-day cardiac disease cases were identified, of whom 6,181 (36.85%) had at least one adverse event. Patients with adverse events stayed approximately 7 days longer and had four times the case fatality rate than those without. After adjustment for age and co-morbidity, the presence of an adverse event adds AUS$5,751. The sum of the total cost of adverse events for each DRG was AUS$42.855 million, representing 21.6% of total expenditure on cardiac surgery and adding 27.5% in broad terms to the cardiac surgery budget.

KW - Adverse events

KW - Costs

KW - Health economics

KW - Patient safety

UR - http://www.scopus.com/inward/record.url?scp=35748984935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35748984935&partnerID=8YFLogxK

U2 - 10.1007/s10198-006-0036-z

DO - 10.1007/s10198-006-0036-z

M3 - Article

VL - 8

SP - 339

EP - 346

JO - European Journal of Health Economics

JF - European Journal of Health Economics

SN - 1618-7598

IS - 4

ER -